Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ENTA Enanta Pharmaceuticals Inc

13,00

0,24 (1,88%)

Zuletzt aktualisiert: 18:16:40

Verzögert um 15 Minuten

Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals

Enanta Pharmaceuticals (NASDAQ:ENTA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Enanta Pharmaceuticals Charts.

Enanta Pharmaceuticals (NASDAQ:ENTA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Enanta Pharmaceuticals Charts.

News Enanta Pharmaceuticals Inc

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 8 Mai 2024 (20 Stunden vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (21 Stunden vor) • Edgar (US Regulatory)

Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
Dienstag 7 Mai 2024 (2 Tage vor) • Business Wire

Form 8-K - Current report
Montag 6 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
Montag 6 Mai 2024 (3 Tage vor) • Business Wire

Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dienstag 30 April 2024 (1 Woche vor) • Business Wire

Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
Dienstag 30 April 2024 (1 Woche vor) • Business Wire

Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
Montag 29 April 2024 (1 Woche vor) • Business Wire

Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Mittwoch 17 April 2024 (3 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Enanta Pharmaceuticals Inc News-Artikel

Energy Select Sector SPDR

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen